1,336 results match your criteria: "Centre Hospitalier Universitaire de Bordeaux .[Affiliation]"
Rheumatology (Oxford)
November 2024
Department of Rheumatology and National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, Hôpital Bicêtre, Université Paris-Saclay, Le Kremlin Bicêtre, France.
Objectives: To evaluate the effectiveness of short message service (SMS) and/or email reminders in improving influenza vaccination coverage rates among rheumatoid arthritis (RA) patients treated with anti-TNF therapies, and to identify factors associated with vaccination.
Methods: A nested randomized controlled trial in the ART e-cohort, an ongoing French nationwide multicentre prospective cohort of RA patients treated with anti-TNF therapy. Patients were 1:1 randomized, with stratification on age.
N Engl J Med
November 2024
From the QEII Health Sciences Centre, Dalhousie University, Halifax, NS (J.L.S., R.P., A.A.), Western University, London, ON (A.S.L.T., L.J.G.), the Population Health Research Institute (J.S.H.) and Hamilton Health Sciences Centre (G.A.), Hamilton, ON, the University of Ottawa Heart Institute (G.M.N., P.B.N.), the McGill University Health Centre (V.E.), the Montreal Heart Institute (L.R., K.D.), and Centre Hospitalier de l'Universitaire de Montreal (J.-M.R.), Montreal, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC (J.-F.R.), Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec (J.-F.S., I.N.), the University of British Columbia, Vancouver (M.D.), Kelowna General Hospital, Kelowna, BC (C.L.), the University of Ottawa, Ottawa (G.A.W.), and the University of Calgary, Calgary, AB (V.K., S.W.) - all in Canada; Vanderbilt University Medical Center, Nashville (W.G.S., A.K.); Centre Hospitalier Universitaire de Bordeaux, L'institut des Maladies du Rythme Cardiaque, Bordeaux (F.S.), and Centre Hospitalier Universitaire de Nancy, Nancy (C.C.) - both in France; and St. Mary's General Hospital, Passaic, NJ (U.J.).
Background: Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular tachycardia. Whether catheter ablation is more effective than antiarrhythmic drugs as a first-line therapy in patients with ventricular tachycardia is uncertain.
View Article and Find Full Text PDFPrenat Diagn
December 2024
Centre de Génétique Humaine, Centre Hospitalier Universitaire de Besançon, Université de Franche-Comté, Besançon, France.
Purpose: MYRF-related cardiac-urogenital syndrome (MYRF-CUGS) is a rare condition associated with heterozygous MYRF variants. The description of MYRF-CUGS phenotype is mostly based on postnatal cases and 36 affected individuals have been published so far. We aim now to delineate the prenatal phenotype of MYRF-CUGS by reporting clinical data from fetuses and neonates with a pathogenic MYRF variant.
View Article and Find Full Text PDFBMJ Open
November 2024
Service de prévention, CHU de Bordeaux, Bordeaux, France.
Introduction: In 2021, among French women who smoked when they knew they were pregnant, 59% still smoked at the end of pregnancy. Support for pregnant women to stop smoking must include a structured organisational perspective. The main objective of the study is to evaluate the effectiveness of the 5A-QUIT-N organisational intervention on smoking cessation at delivery among pregnant women who smoke during pregnancy.
View Article and Find Full Text PDFActa Ophthalmol
November 2024
Univ. Bordeaux, INSERM, BPH, U1219, Bordeaux, France.
Lancet Reg Health Eur
December 2024
Assistance Publique - Hôpitaux de Paris, Nord. Hôpital Bichat-Claude Bernard, Service des Maladies Infectieuses et Tropicales, F75018, Paris, France.
Therapie
October 2024
Inserm, Aix-Marseille université, U1106, 13005 Marseille, France; Service de pharmacologie clinique et pharmacosurveillance, unité de pharmacoépidémiologie, Assistance publique-Hôpitaux de Marseille, 13009 Marseille, France; Service de pharmacologie clinique et pharmacosurveillance, centre d'évaluation et d'information sur la pharmacodépendance - addictovigilance, Assistance publique-Hôpitaux de Marseille, 13009 Marseille France.
The French Addictovigilance Network has been using data from the French Heath insurance since the late 1990s to assess prescription drug abuse. In this narrative review, we illustrate the inputs of pharmacoepidemiology in addictovigilance based on the experience of the French Addictovigilance Network. The review focuses on pharmacoepidemiology using the French National Health Data System.
View Article and Find Full Text PDFGene
January 2025
Laboratoire Maladies Rares, Génétique et Métabolisme, Bordeaux University INSERM U1211, Bordeaux, France; Service de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. Electronic address:
Oculocutaneous albinism type 1 is caused by variants in the TYR (tyrosinase) gene. We describe a family with two affected sibs who inherited the pathogenic missense TYR variant c.1146C > A;p.
View Article and Find Full Text PDFRadiology
November 2024
IMADIS Groupe, 48 rue Quivogne, 69002 Lyon, France.
Eur J Anaesthesiol
March 2025
From the Département d'Anesthésie-Réanimation, Université Jean Monnet Saint Etienne, CHU Saint Etienne, F-42023, Saint Etienne, France (LP, GD, LF SM), the Service d'Anesthésie et de Réanimation, Université d'Aix Marseille, Assistance Publique Hôpitaux de Marseille,, Hôpital Nord, Marseille, France (BP, JA, ML), the Département d'Anesthésie Réanimation, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France (BB, PI), the Service d'Anesthésie Réanimation & Médecine Péri-opératoire, Centre Hospitalier Universitaire de Poitiers, Poitiers, 86021, France; Inserm U1070, Université de Poitiers, Poitiers, France (PAG, MB), the Service d'Anesthésie et de Réanimation, Hôpital Universitaire Louis Pradel, Hospices Civils de Lyon, 69500, Lyon, France (JLF), the Département Anesthésie et Réanimation, Centre Hospitalier Universitaire Nîmes, Nîmes, France (YG), the Service d'Anesthésie, Centre hospitalier et universitaire de Lille, F-59037 Lille, France (GL), the Service Anesthésie et Réanimation, Centre Medico-chirurgical Magellan, Centre Hospitalier Universitaire de Bordeaux, Pessac, France (AO), the Département d'Anesthésie et de Réanimation, Centre Hospitalier Universitaire de Caen, Caen, France (MOF), Service d'Anesthésie-Réanimation Chirurgicale NHC - Hôpitaux Universitaires de Strasbourg, 67094 Strasbourg cedex, France (PMM), AP-HP, 26930, Groupe Hospitalier Universitaire APHP-Sorbonne Université, site Pitié-Salpêtrière, Département d'Anesthésie Réanimation, F-75013, Paris, Île-de-France, France (DE), the Département d'Anesthésie et de Réanimation, Centre Hospitalier Universitaire, Dijon, France (BB), the Département d'Anesthésie, Réanimation et Médecine Périopératoire, Groupe Hospitalier Universitaire Cochin, Paris, France (AG), AP-HP Nord, the Département d'Anesthésie Réanimation, CHU Bichat-Claude-Bernard, Paris, France. Université Paris-Cité, France (PM), the Laboratoire d'immunologie et EA7426, Hospices Civils de Lyon, Groupement Hospitalier Edouard Herriot, Lyon, France (GM), the Département d'Anesthésie et de Réanimation, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France (ACL), Direction de la Recherche Clinique, Centre Hospitalier Universitaire de Clermont-Ferrand, Unité de Biostatistiques, Clermont-Ferrand, France (BP).
Background: Stress due to surgical trauma decreases postoperative lymphocyte counts (LCs), potentially favouring the occurrence of postoperative infections (PIs).
Objectives: We aimed to determine whether postoperative lymphopaenia following thoracic or gastrointestinal cancer surgery is an independent risk factor for PIs and to identify modifiable factors related to anaesthesia and surgical procedures that might affect its occurrence.
Study Design: The EVALYMPH study was a prospective, multicentre cohort study with a 30-day patient follow-up.
Ann Clin Transl Neurol
December 2024
Inserm CIC1436, Toulouse University Hospital, Toulouse, France.
Background: While advances in endovascular thrombectomy (EVT) have led to high reperfusion rates, most patients treated with EVT do not avoid disability. Post-reperfusion hemorrhagic transformation (HT) is a potential target for improving outcomes. This study examined pretreatment blood-brain barrier (BBB) disruption in tissue that would subsequently become part of the final infarct to evaluate its role in post-EVT HT.
View Article and Find Full Text PDFPLoS One
October 2024
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Introduction: HIV replication leads to a change in lymphocyte phenotypes that impairs immune protection against opportunistic infections. We examined current HIV replication as an independent risk factor for tuberculosis (TB).
Methods: We included people living with HIV from 25 European cohorts 1983-2015.
Clin Res Hepatol Gastroenterol
December 2024
Service de Gastroentérologie, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, and INSERM U1111-CIRI, Lyon, France.
Background: ReFLECT was a French, prospective, multicenter, observational cohort study evaluating the effectiveness and safety of the infliximab (IFX) biosimilar CT-P13 in a real-world setting. Here, we describe the results for adults with inflammatory bowel disease (IBD).
Methods: Eligible patients with IBD were recruited and received intravenous CT-P13 induction and/or maintenance therapy; patients were either naive to IFX (IFX-naive) or previously treated with IFX originator or another IFX biosimilar (IFX-switched).
Sci Rep
October 2024
Unité Pédagogique de Dermatologie et Infectiologie, Unité de Formation et de Recherche des Sciences Médicales, Université Félix Houphouet-Boigny, Abidjan, Côte d'Ivoire.
Observational studies suggest a reduction in fatal or severe COVID-19 disease with the use of ACE2 inhibitors and statins. We implemented a randomized controlled tree-arm open label trial evaluating the benefits of adding telmisartan (TLM) or atorvastatin (ATV) to lopinavir boosted ritonavir (LPVr) on the SARS-CoV-2 nasopharyngeal viral load in patients with mild / moderate COVID-19 infection in Côte d'Ivoire. RT-PCR positive COVID-19 patients ≥ 18 years, with general or respiratory symptoms for less than 7 days were randomized (1:1:1) to receive LPVr (400 mg/100 mg twice daily), LPVr + TLM (10 mg once daily) or LPVr + ATV (20 mg once daily) for 10 days.
View Article and Find Full Text PDFArq Bras Cardiol
October 2024
Centre Hospitalier Universitaire de Bordeaux, Bordeaux, Nouvelle-Aquitaine - França.
Transplantation
October 2024
Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
Background: In kidney transplantation, molecular diagnostics may be a valuable approach to improve the precision of the diagnosis. Using next-generation sequencing (NGS), we aimed to identify clinically relevant archetypes.
Methods: We conducted an Illumina bulk RNA sequencing on 770 kidney biopsies (540 kidney recipients) collected between 2006 and 2021 from 11 European centers.
JACC Clin Electrophysiol
December 2024
Institut Hospitalo-Universitaire Institut des Maladies du Rythme Cardiaque, Electrophysiology and Heart Modeling Institute, Bordeaux, France; Haut-Lévêque University Hospital, Bordeaux, France.
Circ Cardiovasc Interv
November 2024
Department of Interventional Cardiology and Cardiothoracic Surgery, Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, TX (N.S.K., M.J.R.).
Eur Stroke J
October 2024
Department of Medicine, Division of Neurology, The Ottawa Hospital, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada.
Background: Patients with acute basilar artery occlusion (BAO) and low-to-moderate symptoms (National Institutes of Health Stroke Scale [NIHSS] < 10) are poorly represented in thrombectomy trials. Our objective is to compare thrombectomy and best medical management (BMT) in this population.
Methods: We compared data of all consecutive patients presenting with an initial NIHSS < 10 and acute symptomatic BAO included in two registries.
Support Care Cancer
October 2024
AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Service Soins Palliatifs, Accompagnement Et Soins de Support, 47-83 Bd de L'Hôpital, 75013, Paris, France.
Am J Clin Dermatol
November 2024
Istituto Oncologico Veneto IOV-IRCCS, Via Gattamelata, 64, Padua, Italy.
Fr J Urol
October 2024
Centre hospitalier universitaire de Nice, Nice, France. Electronic address:
Cancer Radiother
November 2024
UMR_S 938, service d'oncologie radiothérapie, hôpital Tenon, centre de recherche Saint-Antoine, institut universitaire de cancérologie, Sorbonne université, AP-HP, Paris, France.
The term "event" covers a wide range of concrete situations in radiation oncology, from particularly intense radiation-related side effects to the possibility of technical or human error. Although quality procedures are an integral part of radiotherapy oncology department operations ensuring the analysis and prevention of such events, their occurrence during radiation treatment still has a significant impact on patients and their experience of the treatment process, as well as on health professionals. These practical, emotional and symbolic impacts are all the greater when the event occurs in the aftermath of an error.
View Article and Find Full Text PDFGenet Med
January 2025
Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: